Revvityブログ
発見から治療までのイノベーションを促進
Latest
Revvity and mo:re collaborate to improve reproducibility in 3D model research.
Physiological Model Solutions
January 22, 2026 - 2 min read
NGS
Ribosomal RNA fragments in small RNA-seq: biological signals or artifacts?
January 15, 2026 -
4 min read
Functional Genomic Screening
How to achieve tight temporal control over CRISPRa, CRISPRi, and CRISPRko applications.
January 12, 2026 -
2 min read
Assay Development Workflows
Decoding tirzepatide’s dual agonism with advanced pharmacology assays.
January 8, 2026 -
7 min read
NGS
Automated normalization of small RNA libraries with AutoNorm™ technology.
January 7, 2026 -
1 min read
Reproductive Health
Uniting for early detection: the role of Revvity in DMD screening.
January 1, 2026 -
6 min read
NGS
Enhancing whole blood RNA-seq with globin depletion strategies.
December 31, 2025 -
3 min read
Cell Signaling Analysis
Study reveals multifaceted roles of β-arrestins in GPCR internalization, including GLP-1R.
December 22, 2025 -
5 min read
Cell and Gene Therapy
Addressing technical barriers in primary T cell research.
December 19, 2025 -
4 min read
Cell and Gene Therapy
From policy to practice: what FDA's 2025 direction means for your precision medicine pipeline.
December 8, 2025 -
5 min read
Cancer
Enhancing CAR NK-cell research with chemically defined serum-free culture solutions.
December 5, 2025 -
3 min read
